A new "digital organism" could simulate how a potential drug or genetic change moves through molecules and cells and eventually people, according to a new Nature Medicine paper out Thursday.
Why it matters: Better AI simulations could streamline biology and help researchers screen ideas earlier and focus experiments on the most promising candidates to catch risks sooner.
